Jason Loveridge, Ph.D.
Chief Executive Officer (CEO)
Chairman of the Management Board
Jason Loveridge joined 4SC AG as CEO in September 2016. He has more than 20 years of international experience across Europe, Asia and the US in senior management positions in life sciences companies and as an investment professional dealing in both privately held and publicly traded companies. Additionally, he has substantial transactional experience in the sale and partnering of biotechnology assets.
Jason Loveridge graduated in Biochemistry and Microbiology from the University of New South Wales, Australia, and holds a Ph.D. in Biochemistry from the University of Adelaide, Australia.
Susanne Danhauser-Riedl, M.D.
Chief Medical Officer (CMO)
Susanne Danhauser-Riedl strengthens the management team of 4SC since April 2015 as CMO. She has long-standing experience in the areas hematology and oncology and is responsible for the clinical trials of 4SC.
She has more than 20 years of experience in leading positions, in the scientific and clinical practice and in the pharmaceutical industry, in medical affairs and clinical development. Before joining 4SC, she was in charge of medical affairs for the hematology / oncology products of GlaxoSmithKline from clinical development to commercialization in Germany.
Susanne Danhauser-Riedl started her medical education at the Regensburg University and earned her medical degree from the Technical University of Munich.